Arcus Biosciences Executives Sell Shares to Cover Tax Obligations

Reporter NameRelationshipTypeAmountSEC FilingRosen Terry JChief Executive Officer, 10% OwnerSell$1,203,959Form 4Jaen Juan C.President, 10% OwnerSell$466,869Form 4Goeltz Ii Robert C.Chief Financial Officer, 10% OwnerSell$278,739Form 4Jarrett JenniferChief Operating Officer, 10% OwnerSell$466,869Form 4Azoy AlexanderChief Accounting Officer, 10% OwnerSell$195,433Form 4Tang Carolyn C.General Counsel, 10% OwnerSell$318,496Form 4Markus RichardChief Medical Officer, 10% OwnerSell$210,144Form 4Several executives at Arcus Biosciences, including the CEO, President, CFO, COO, Chief Accounting Officer, General Counsel, and Chief Medical Officer, have sold shares of the company's common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs). Terry J Rosen, CEO, sold 54,691 shares at weighted average prices of $21.8843 and $22.1595, totaling $1,203,959. Rosen now directly owns 2,194,809 shares. Juan C. Jaen, President, sold 21,208 shares at weighted average prices of $21.8843 and $22.1595, totaling $466,869. Jaen directly owns 346,012 shares and indirectly owns 954,063 shares through a trust. Goeltz II Robert C., CFO, sold 12,662 shares at weighted average prices of $21.8843 and $22.1595, totaling $278,739. Goeltz directly owns 74,476 shares. Jennifer Jarrett, COO, sold 21,208 shares at weighted average prices of $21.8843 and $22.1595, totaling $466,869. Jarrett directly owns 193,024 shares. Azoy Alexander, Chief Accounting Officer, sold 8,832 shares at prices ranging from $21.42 to $22.59, totaling $195,433. Alexander directly owns 18,531 shares. Carolyn C. Tang, General Counsel, sold 14,468 shares at weighted average prices of $21.8843 and $22.1595, totaling $318,496. Tang directly owns 124,734 shares. Markus Richard, Chief Medical Officer, sold 9,546 shares at weighted average prices of $21.8843 and $22.1595, totaling $210,144. Richard directly owns 65,647 shares.